58916 studies found for:    "Physiological Effects of Drugs"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Rate Control in Atrial Fibrillation II
Conditions: Atrial Fibrillation;   Permanent Atrial Fibrillation
Interventions: Drug: Metoprolol;   Drug: Diltiazem
2 Recruiting Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
Condition: Schizophrenia
Interventions: Drug: Dextroamphetamine;   Drug: Placebo
3 Recruiting Ketamine Infusions for PTSD and Treatment-Resistant Depression
Conditions: Depressive Disorder, Treatment-Resistant;   Stress Disorders, Post-Traumatic
Intervention: Drug: Ketamine
4 Recruiting Intrathecal Rituximab in Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Chronic Progressive;   Nervous System Diseases
Interventions: Drug: Rituximab IT;   Drug: methylprednisolone IV;   Drug: Rituximab IV
5 Recruiting Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users
Conditions: Alcohol Dependence;   Alcohol Use Disorder
Intervention: Drug: XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
6 Recruiting ADC-1013 First-in-Human Study
Conditions: Neoplasms;   Solid Tumors
Intervention: Biological: ADC-1013
7 Recruiting Combination Chemotherapy or 90-Yttrium Ibritumomab Tiuxetan and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Relapsed Diffuse Large B-cell Non-Hodgkin Lymphoma
Conditions: Recurrent Diffuse Large B-Cell Lymphoma;   Refractory Diffuse Large B-Cell Lymphoma
Interventions: Radiation: Yttrium Y 90 Ibritumomab tiuxetan;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Biological: Rituximab;   Procedure: Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis
8 Recruiting The Effect of Uric Acid Lowering in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Febuxostat
9 Recruiting Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Conditions: Spinal Cord Injury;   Acute Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Zoledronic acid;   Drug: Placebo
10 Recruiting Intra-Peritoneal Local Anaesthesia After Cytoreductive Surgery
Condition: Pain
Interventions: Drug: Ropivacaine;   Drug: Saline
11 Recruiting Perimenopausal Effects of Estradiol on Reward Responsiveness
Condition: Perimenopausal Depression
Interventions: Drug: Estradiol;   Drug: Progesterone
12 Active, not recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
13 Completed Oral Testosterone for the Treatment of Hypogonadism in Males
Condition: Hypogonadism
Intervention: Drug: TSX-002
14 Enrolling by invitation Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury Previously Treated With Teriparatide
Conditions: Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Alendronate;   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
15 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
16 Recruiting Vascular Function and Uterine Fibroids
Condition: Leiomyoma
Interventions: Device: Brachial artery catheter;   Drug: Acetylcholine;   Drug: Nitroprusside;   Drug: Norepinephrine;   Drug: Nitroprusside and phenylephrine
17 Completed Liraglutide as add-on to Insulin in Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Liraglutide;   Drug: Placebo
18 Completed Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Condition: Male Hypogonadism
Interventions: Drug: Oral testosterone undecanoate, LPCN 1021;   Drug: Topical testosterone gel 1.62 %
19 Completed
Has Results
Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers
Condition: Hereditary Angioedema (HAE)
Intervention: Drug: Icatibant (30 mg)
20 Active, not recruiting 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
Conditions: Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Teriparatide;   Device: Vibration

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years